Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Validation of a metabolite panel for early diagnosis of type 2 diabetes.
Carter TC, Rein D, Padberg I, Peter E, Rennefahrt U, David DE, McManus V, Stefanski E, Martin S, Schatz P, Schrodi SJ. Carter TC, et al. Metabolism. 2016 Sep;65(9):1399-408. doi: 10.1016/j.metabol.2016.06.007. Epub 2016 Jun 26. Metabolism. 2016. PMID: 27506746 Free PMC article.
BACKGROUND: Accurate, early diagnosis of type 2 diabetes (T2D) would enable more effective clinical management and a reduction in T2D complications. ...RESULTS: A panel of 10 metabolites discriminated better between T2D cases and c …
BACKGROUND: Accurate, early diagnosis of type 2 diabetes (T2D) would enable more effective clinical manag …
Discovery of metabolite profiles of metabolic syndrome using untargeted and targeted LC-MS based lipidomics approach.
Gong LL, Yang S, Zhang W, Han FF, Lv YL, Xuan LL, Liu H, Liu LH. Gong LL, et al. J Pharm Biomed Anal. 2020 Jan 5;177:112848. doi: 10.1016/j.jpba.2019.112848. Epub 2019 Aug 29. J Pharm Biomed Anal. 2020. PMID: 31479998
Metabolic syndrome (MetS) is an important risk factor for type 2 diabetes, cardiovascular diseases and all-cause morbidity and mortality. ...Using comprehensive screening and validation workflow, we identified a panel of three metabolites
Metabolic syndrome (MetS) is an important risk factor for type 2 diabetes, cardiovascular diseases and all-cause morbid …
Metabolomic biomarkers of pancreatic cancer: a meta-analysis study.
Mehta KY, Wu HJ, Menon SS, Fallah Y, Zhong X, Rizk N, Unger K, Mapstone M, Fiandaca MS, Federoff HJ, Cheema AK. Mehta KY, et al. Oncotarget. 2017 Aug 18;8(40):68899-68915. doi: 10.18632/oncotarget.20324. eCollection 2017 Sep 15. Oncotarget. 2017. PMID: 28978166 Free PMC article.
Pancreatic cancer (PC) is an aggressive disease with high mortality rates, however, there is no blood test for early detection and diagnosis of this disease. ...Furthermore, since the incidence of PC is associated with metabolic syndrome and Type 2
Pancreatic cancer (PC) is an aggressive disease with high mortality rates, however, there is no blood test for early detection and …
Feedback